미국 · 보도자료 · BriaCell Therapeutics Corp. · 2026-10-06 11:30
SITC 2026 연례회의서 포스터 4건 발표 예정
PHILADELPHIA and VANCOUVER, British Columbia, Oct. 06, 2026 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXL) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, and its majority-owned subsidiary, BriaPro Therapeutics Corp. (“BriaPro”), today announced that four abstracts featuring precli
BriaCell Therapeutics Corp. 다른 공시·급등 이유 보기 · GK의 공시레이더 — 미국·한국 실시간 공시